JP2004500406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004500406A5 JP2004500406A5 JP2001570600A JP2001570600A JP2004500406A5 JP 2004500406 A5 JP2004500406 A5 JP 2004500406A5 JP 2001570600 A JP2001570600 A JP 2001570600A JP 2001570600 A JP2001570600 A JP 2001570600A JP 2004500406 A5 JP2004500406 A5 JP 2004500406A5
- Authority
- JP
- Japan
- Prior art keywords
- membered
- group
- analogue
- composition
- proliferation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 230000010261 cell growth Effects 0.000 claims 3
- 230000004663 cell proliferation Effects 0.000 claims 3
- 229920000768 polyamine Polymers 0.000 claims 3
- 230000035755 proliferation Effects 0.000 claims 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 125000001931 aliphatic group Chemical class 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 125000002723 alicyclic group Chemical group 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 238000002399 angioplasty Methods 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 238000007917 intracranial administration Methods 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000865 liniment Substances 0.000 claims 1
- 229940040145 liniment Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19183900P | 2000-03-24 | 2000-03-24 | |
| PCT/US2001/040360 WO2001072685A2 (en) | 2000-03-24 | 2001-03-23 | Polyamine analogues as cytotoxic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004500406A JP2004500406A (ja) | 2004-01-08 |
| JP2004500406A5 true JP2004500406A5 (https=) | 2005-02-17 |
Family
ID=22707114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570600A Pending JP2004500406A (ja) | 2000-03-24 | 2001-03-23 | 細胞毒性剤としてのポリアミン類似体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6872852B2 (https=) |
| EP (1) | EP1296931B1 (https=) |
| JP (1) | JP2004500406A (https=) |
| KR (1) | KR20020081433A (https=) |
| CN (1) | CN1426391A (https=) |
| AT (1) | ATE327973T1 (https=) |
| AU (2) | AU5173501A (https=) |
| CA (1) | CA2403814A1 (https=) |
| DE (1) | DE60120162T2 (https=) |
| ES (1) | ES2271000T3 (https=) |
| HU (1) | HUP0400494A3 (https=) |
| IL (1) | IL151692A0 (https=) |
| PL (1) | PL365473A1 (https=) |
| RU (1) | RU2002128917A (https=) |
| WO (1) | WO2001072685A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030013772A1 (en) * | 2000-02-23 | 2003-01-16 | Murphy Michael A. | Composition, synthesis and therapeutic applications of polyamines |
| WO2002053519A2 (en) * | 2001-01-08 | 2002-07-11 | Mediquest Therapeutics, Inc. | Hydrophobic polyamine analogs and methods for their use |
| USRE43327E1 (en) | 2001-01-08 | 2012-04-24 | Aminex Therapeutics, Inc. | Hydrophobic polyamine analogs and methods for their use |
| IL147812A0 (en) * | 2001-03-16 | 2002-08-14 | N S T Neurosurvival Technologi | Method for targeting chemical compounds to cells and pharmaceutical compositions used therein |
| JP4414219B2 (ja) | 2001-07-23 | 2010-02-10 | メルク セローノ ソシエテ アノニム | Ｃ−ｊｕｎ−ｎ−末端キナーゼ（ｊｎｋ）インヒビターとしてのアリールスルホンアミド誘導体 |
| WO2003013245A1 (en) | 2001-08-07 | 2003-02-20 | Wisconsin Alumni Research Foundation | Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy |
| US7199267B1 (en) * | 2005-10-21 | 2007-04-03 | Mediquest Therapeutics, Inc. | Recognition of oligiosaccaride molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases |
| EP2149568A1 (en) * | 2008-07-22 | 2010-02-03 | Bracco Imaging S.p.A | Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| WO2013184202A1 (en) | 2012-06-08 | 2013-12-12 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Fbxo3 inhibitors |
| WO2015089087A1 (en) | 2013-12-09 | 2015-06-18 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compositions and methods for treating respiratory injury or disease |
| CN104892449B (zh) * | 2014-03-06 | 2017-06-13 | 天津红日药业股份有限公司 | 一种精胺类似物及其药用盐的制备方法和用途 |
| SG11201810861PA (en) * | 2014-12-10 | 2019-01-30 | Univ Pittsburgh Commonwealth Sys Higher Education | Compositions and methods for treating diseases and conditions |
| HUE052620T2 (hu) | 2016-03-25 | 2021-05-28 | Aminex Therapeutics Inc | Biológiailag hozzáférhetõ poliaminok |
| US11905268B2 (en) | 2018-08-10 | 2024-02-20 | University Of Central Florida Research Foundation, Inc. | Anthranilic acid derivatives and their use in the treatment of human cancers |
| JP2023545674A (ja) | 2020-09-30 | 2023-10-31 | アミネックス セラピューティクス， インコーポレイテッド | ポリアミン輸送阻害剤およびｄｆｍｏの配合原薬 |
| US11752118B2 (en) * | 2020-12-02 | 2023-09-12 | Gongwin Biopharm Co., Ltd | Method for treating melanoma |
| EP4169902A1 (en) * | 2021-10-25 | 2023-04-26 | Consejo Superior de Investigaciones Científicas (CSIC) | Spermine derivatives as heparin antidotes |
| CN118541146B (zh) * | 2022-12-23 | 2025-04-25 | 中国医学科学院基础医学研究所 | 精胺衍生物及其在疾病中的治疗用途 |
| US12605349B2 (en) | 2024-09-05 | 2026-04-21 | Orbus Therapeutics, Inc. | Methods of treating grade 3 astrocytoma |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3634316A (en) | 1968-08-23 | 1972-01-11 | Showa Denko Kk | Sulfur-vulcanizable natural and synthetic rubbery polymers containing xylylene diamines as antiozonants |
| US4851447A (en) | 1983-12-06 | 1989-07-25 | Merrell Dow Pharmaceuticals Inc. | N-2,3-butadienyl-1,4-butanediamine derivatives |
| NZ212053A (en) | 1984-05-17 | 1988-02-29 | Merrell Dow Pharma | Polyamine containing pharmaceutical compositions for treating neoplasms |
| AU628174B2 (en) | 1989-05-23 | 1992-09-10 | Merrell Dow Pharmaceuticals Inc. | A method of potentiating cell-mediated immunity utilizing polyamine derivatives |
| ATE313321T1 (de) | 1991-08-23 | 2006-01-15 | Nps Pharma Inc | Kalzium-rezeptor aktive verbindungen |
| ATE175188T1 (de) * | 1993-02-23 | 1999-01-15 | Merrell Pharma Inc | Polyaminderivate als strahlenschutzmittel |
| US5677350A (en) | 1995-06-07 | 1997-10-14 | Wisconsin Alumni Research Foundation | Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes |
| US5962533A (en) * | 1996-02-06 | 1999-10-05 | University Of Florida Research Foundation, Inc. | Hydroxy polyamines |
| JP4044728B2 (ja) * | 1997-07-15 | 2008-02-06 | メディクエスト セラピューティックス インク | 治療および診断薬剤としての新規なポリアミンアナログ |
| US5886185A (en) * | 1997-11-20 | 1999-03-23 | Development Center For Biotechnoloy | Polyamine-linked acridine dimers |
-
2001
- 2001-03-23 ES ES01925146T patent/ES2271000T3/es not_active Expired - Lifetime
- 2001-03-23 AU AU5173501A patent/AU5173501A/xx active Pending
- 2001-03-23 PL PL01365473A patent/PL365473A1/xx not_active Application Discontinuation
- 2001-03-23 AU AU2001251735A patent/AU2001251735B2/en not_active Ceased
- 2001-03-23 WO PCT/US2001/040360 patent/WO2001072685A2/en not_active Ceased
- 2001-03-23 US US10/239,521 patent/US6872852B2/en not_active Expired - Fee Related
- 2001-03-23 EP EP01925146A patent/EP1296931B1/en not_active Expired - Lifetime
- 2001-03-23 JP JP2001570600A patent/JP2004500406A/ja active Pending
- 2001-03-23 HU HU0400494A patent/HUP0400494A3/hu unknown
- 2001-03-23 KR KR1020027011949A patent/KR20020081433A/ko not_active Withdrawn
- 2001-03-23 CN CN01807059A patent/CN1426391A/zh active Pending
- 2001-03-23 RU RU2002128917/04A patent/RU2002128917A/ru unknown
- 2001-03-23 AT AT01925146T patent/ATE327973T1/de not_active IP Right Cessation
- 2001-03-23 CA CA002403814A patent/CA2403814A1/en not_active Abandoned
- 2001-03-23 DE DE60120162T patent/DE60120162T2/de not_active Expired - Fee Related
- 2001-03-23 IL IL15169201A patent/IL151692A0/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004500406A5 (https=) | ||
| ES2436540T3 (es) | Nuevas imidazoquinolinas sustituidas | |
| JP2001247459A (ja) | 癌の組み合わせ療法 | |
| RU2264401C3 (ru) | Производные хинуклидина, способ их получения, фармацевтическая композиция, способ лечения и промежуточные вещества | |
| WO2001072685B1 (en) | Polyamine analogues as cytotoxic agents | |
| JP2009507909A5 (https=) | ||
| JPH01186893A (ja) | 水溶性カンプトテシン類似体 | |
| JP2013532729A5 (https=) | ||
| WO2005067900A3 (en) | Azabenzofuran substituted thioureas as inhibitors of viral replication | |
| JP5634510B2 (ja) | イミノ糖ならびにブニヤウイルスおよびトガウイルス疾患を治療する方法 | |
| IL287470B1 (en) | Derivatives of 6-methyl-6,1-dihydro-7H-pyrrolo[3,2-c]pyridin-7-one or of an acceptable pharmaceutical salt thereof and pharmaceutical preparations containing them. | |
| JP2018048178A (ja) | オキサビシクロヘプタン類、および再灌流障害の治療のためのオキサビシクロヘプタン類 | |
| JPH06500078A (ja) | Ｔｎｆ抑制剤 | |
| KR100655251B1 (ko) | 바이러스성 심근염의 예방 또는 치료용 의약 조성물 | |
| JP2001520994A5 (https=) | ||
| WO2008124823A1 (en) | Method of treating melanoma | |
| JP2003501469A5 (https=) | ||
| CN110612286A (zh) | 氰基取代的稠合双环衍生物及其制备方法和用途 | |
| US11319273B2 (en) | Lipophilic curcumin analogs and methods of inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia | |
| CA2485201A1 (en) | Camptothecins with a modified lactone ring | |
| WO2010130147A1 (zh) | 乳酸咯萘啶及其药物组合物和用途 | |
| ES2378374T3 (es) | Inhibidores de la PDE 4 para el tratamiento de la cistitis intersticial | |
| WO2011113300A1 (zh) | 能够抑制化疗药物引起的毒副反应的药物 | |
| JPWO2007046456A1 (ja) | 新規水溶性プロドラッグを含有する、膵臓癌、卵巣癌または肝臓癌の予防または治療剤 | |
| US8492413B2 (en) | Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer |